Menarini Asia-Pacific is thrilled to announce the appointment of Glen Godresse as the company's Chief Executive Officer, effective March 1st, 2024. Bringing over two decades of profound expertise in the pharmaceutical industry, Glen's illustrious career spans more than 25 years of dedicated service in various leadership roles.

Glen joined the Menarini Group in 2013, and since then, he has been instrumental in steering the company towards new heights. His journey within Menarini has seen him occupy several key positions, including the General Manager for Australia and New Zealand, followed by his role as the Regional Chief Marketing Officer. Glen's leadership has been pivotal in shaping the strategic direction of the company, demonstrating a keen insight into the pharmaceutical sector and a deep commitment to excellence.

As the new CEO of Menarini Asia-Pacific, Glen Godresse is set to lead the company into a promising future, with a strong focus on investing in and nurturing both proprietary and partnered brands. Under his guidance, Menarini Asia-Pacific is committed to leveraging its flexible omnichannel commercialisation model to meet and exceed the evolving needs of patients across a diverse range of developed and emerging markets, as well as therapeutic areas.

The company's dedication to addressing unmet patient needs remains unwavering, with Glen at the helm steering Menarini Asia-Pacific's strategies and operations. His vision for the company aligns with Menarini's long-standing mission to enhance healthcare outcomes for patients worldwide by providing innovative and effective medical solutions.

Glen's appointment is a testament to Menarini Asia-Pacific's commitment to leadership excellence and its relentless pursuit of growth and innovation in the pharmaceutical industry. The company looks forward to a future filled with success and advancements in healthcare, under the capable leadership of Glen Godresse.